1. Home
  2. RNXT vs CLST Comparison

RNXT vs CLST Comparison

Compare RNXT & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • CLST
  • Stock Information
  • Founded
  • RNXT 2012
  • CLST 1922
  • Country
  • RNXT United States
  • CLST United States
  • Employees
  • RNXT N/A
  • CLST N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • CLST
  • Sector
  • RNXT Health Care
  • CLST
  • Exchange
  • RNXT Nasdaq
  • CLST Nasdaq
  • Market Cap
  • RNXT 44.6M
  • CLST 51.9M
  • IPO Year
  • RNXT 2021
  • CLST N/A
  • Fundamental
  • Price
  • RNXT $1.32
  • CLST $12.25
  • Analyst Decision
  • RNXT Strong Buy
  • CLST
  • Analyst Count
  • RNXT 2
  • CLST 0
  • Target Price
  • RNXT $7.25
  • CLST N/A
  • AVG Volume (30 Days)
  • RNXT 150.2K
  • CLST 15.4K
  • Earning Date
  • RNXT 08-14-2025
  • CLST 07-30-2025
  • Dividend Yield
  • RNXT N/A
  • CLST N/A
  • EPS Growth
  • RNXT N/A
  • CLST N/A
  • EPS
  • RNXT N/A
  • CLST 0.57
  • Revenue
  • RNXT $240,000.00
  • CLST $11,257,000.00
  • Revenue This Year
  • RNXT $3,104.65
  • CLST N/A
  • Revenue Next Year
  • RNXT $301.89
  • CLST N/A
  • P/E Ratio
  • RNXT N/A
  • CLST $21.93
  • Revenue Growth
  • RNXT N/A
  • CLST 200.91
  • 52 Week Low
  • RNXT $0.75
  • CLST $10.67
  • 52 Week High
  • RNXT $1.69
  • CLST $14.23
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 50.28
  • CLST 53.90
  • Support Level
  • RNXT $1.28
  • CLST $12.53
  • Resistance Level
  • RNXT $1.40
  • CLST $12.75
  • Average True Range (ATR)
  • RNXT 0.07
  • CLST 0.32
  • MACD
  • RNXT -0.01
  • CLST -0.02
  • Stochastic Oscillator
  • RNXT 40.74
  • CLST 16.90

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.

Share on Social Networks: